United States · FDA National Drug Code directory
ENSTILAR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50222-302_0b771976-2050-4eef-bc39-3c853c7c0ac2
- Product NDC
- 50222-302
- Form
- AEROSOL, FOAM
- Composition / generic term
- calcipotriene and betamethasone dipropionate
- Labeler
- LEO Pharma Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20151016
- Source listing expiry
- 20261231
Source-listed ingredients
- CALCIPOTRIENE MONOHYDRATE — 50 ug/g
- BETAMETHASONE DIPROPIONATE — .5 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CAN in 1 CARTON (50222-302-60) / 60 g in 1 CAN · 50222-302-60
- 2 CAN in 1 CARTON (50222-302-66) / 60 g in 1 CAN · 50222-302-66
- 1 CAN in 1 CARTON (50222-302-91) / 60 g in 1 CAN · 50222-302-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →